Viva Biotech Holdings: COMPLETION OF VERY SUBSTANTIAL ACQUISITION IN RELATION TO 80% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL

Nov 13, 2020 07:24

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.